Latest news
Corvus Pharmaceuticals (NASDAQ:CRVS) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTCorvus Pharmaceuticals (NASDAQ:CRVS) Shares Gap Down After Earnings Miss - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:41:40 GMTState Street Corporation (NYSE: STT) discloses 5.3% ownership in Corvus Pharmaceuticals - Stock TitanStock Titan · Fri, 07 Aug 2026 13:17:03 GMTCorvus Pharmaceuticals Inc (CRVS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 10:25:56 GMTCRVS SWOT Analysis: Financial Losses and Growth Potential Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 07:56:16 GMTCorvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:09:15 GMTCorvus Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 03:43:00 GMTCorvus Pharmaceuticals Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:10:04 GMT